ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/08/2023
Back to search
Official data from USPTO
INNOCOLL BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
INNOCOLL BIOTHERAPEUTICS
ST13
US500000090573694Class
5, 10, 42
Filing
90573694
Registration
6657237
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
11/08/2023
Trademark type
Word
Nice classes
5, 10, 42
Filing date
03/11/2021
Registration date
03/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/01/2022
Last transaction
03/01/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Athlone Co. Roscommon, IE
Examiner
COHEN, ROBERT
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Innocoll Pharmaceuticals Limited
Representatives
Camille M. Miller COZEN O'CONNOR
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalveterinary and sanitary preparations for the treatment of woundsburns during surgery; Dressingsfoilscompresseswaddingfoamssemi-liquid matriceall being medical dressingsbandages for skin woundssponges impregnated with antisepticsall for medical use in or on the human and non-human animal body; Dressingsfoilsmedicated compresseswaddingfoamssemi-liquid matrices all being medical dressings; Bandages for skin woundssponges impregnated with antiseptics made from or incorporating collagen all for medical use; Collagen dressingsfoilsmedicated compresseswaddingfoamssemi-liquid matrices all being medical dressings; surgical bandagesfilms being surgical dressingsmembranes being surgical dressings for medical desmoplastic use; Living tissue surgical implants also featuring collagen for use in skin repair and skin improvement; Surgical implants comprising living tissue collagen for wound management and pain relief
Class 10
Medical implant device comprised of an artificial collagen and extracellular matrix composition; Surgical and medical drug delivery patches sold without medication; Surgical implants comprising artificial material for use in skin repair and skin improvement; Surgical and medical implant devices composed of artificial collagen; Artificial collagen constructs for medicalsurgical or veterinary purposes being an implant; Surgical implants comprised of artificial collagen for management of post-operative pain; Surgical implants comprised of artificial collagen for wound management
Class 42
Medical and scientific research services in the field of collagen based drug delivery systems; medical and scientific research services for medicalveterinary and pharmaceutical purposesscientific research in the fields of chemistry and biochemistry; Scientific research consultancy services relating to the development of medical and surgical products; Scientific research services for others performed on a temporary contract basis in the field collagen based drug delivery systems; Scientific research and development of medical and surgical products for othersLaboratory scientific research services relating to operational testing of medical and surgical products; Analysis of technical data for othersanalysis of collagen for research purposes relating to pharmaceuticals for humans and animals
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/01/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/14/2021
PUBO
PUBLISHED FOR OPPOSITION
12/14/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/24/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2021
ALIE
ASSIGNED TO LIE
10/10/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/01/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
09/30/2021
GNSL
LETTER OF SUSPENSION E-MAILED
09/30/2021
CNSL
SUSPENSION LETTER WRITTEN
09/30/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/02/2021
GNRT
NON-FINAL ACTION E-MAILED
09/02/2021
CNRT
NON-FINAL ACTION WRITTEN
09/02/2021
DOCK
ASSIGNED TO EXAMINER
08/27/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/11/2021
NWAP
NEW APPLICATION ENTERED
03/15/2021
Continuous trademark protection
Get notified about every new filing that threatens INNOCOLL BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.